Stay updated on PK and Safety of Uproleselan in Chinese R/R AML Clinical Trial
Sign up to get notified when there's something new on the PK and Safety of Uproleselan in Chinese R/R AML Clinical Trial page.

Latest updates to the PK and Safety of Uproleselan in Chinese R/R AML Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new revision entry (v3.4.2) was added and a funding-status notice was removed; these are administrative updates to the record. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check21 days agoChange DetectedA site-wide funding/status notice was added, informing users about potential delays and that the NIH Clinical Center is open. The page revision was updated from v3.4.0 to v3.4.1.SummaryDifference0.9%

- Check28 days agoChange DetectedThe page now shows a glossary toggle and color-coded highlights for additions (green) and deletions (red) with explanatory notes about how changes are displayed. It also adds Revision: v3.4.0 and references the prior v3.3.4.SummaryDifference1%

- Check42 days agoChange DetectedRevision v3.3.4 was added to the Record History and revision v3.3.3 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedRevision: v3.3.3 was added to the page, and the HHS Vulnerability Disclosure link as well as Revision: v3.3.2 references were removed.SummaryDifference0.2%

- Check92 days agoChange DetectedA new revision entry v3.3.2 was added to the record history and the previous v3.2.0 revision was removed.SummaryDifference0.1%

Stay in the know with updates to PK and Safety of Uproleselan in Chinese R/R AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PK and Safety of Uproleselan in Chinese R/R AML Clinical Trial page.